Rosuvastatin

Latest stories

1d
Business Wire
Sunovion Announces FDA Approval of a New Indication for Aptiom® (eslicarbazepine acetate) as Monotherapy for Partial-Onset SeizuresMARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) a
Sunovion Announces FDA Approval of a New Indication for Aptiom® (eslicarbazepine acetate) as Monotherapy for Partial-Onset Seizures
Business Wire / Posted yesterday
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Aptiom® (eslicarbazepine acetate) as monotherapy... Read more
4d
Medical News Today
A third of very elderly Americans 'on statins without evidence'Statins are being used "without any evidence from testing" among very elderly p
A third of very elderly Americans 'on statins without evidence'
Medical News Today / Posted 4 days ago
Statins are being used "without any evidence from testing" among very elderly people in the US, with levels of prescribing rising from 8.8% in 1999-2000 to 34.1% in 2011-2012 for people who have no vascular disease. Researchers say the prescribing... Read more
2 related stories
24d
Medical News Today
What is a heart attack? What causes a heart attack?Heart attack is the death of a segment of heart muscle caused by the loss of bl
What is a heart attack? What causes a heart attack?
Medical News Today / Posted 24 days ago
Heart attack is the death of a segment of heart muscle caused by the loss of blood supply. The blood supply is usually lost because a coronary artery, one that supplies blood to the heart muscle, has a blood clot, a blockage (coronary thrombosis). If... Read more
5 related stories
29d
Business Wire
Global Statin Market 2015-2019 with AstraZeneca, Merck, Novartis & Pfizer DominatingThe global statin market to decline at a CAGR of 7.50% over the period 2014-201
Global Statin Market 2015-2019 with AstraZeneca, Merck, Novartis & Pfizer Dominating
Business Wire / Posted 29 days ago
The global statin market to decline at a CAGR of 7.50% over the period 2014-2019. Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in... Read more

People in this news